Physician profile
Yi Tang
NPI 1992913222
$2,013.44
in general payments reported to CMS, 2019-2025
12 companies · $49.84 in 2025
The $49.84 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $433 · 2020: $234 · 2021: $286 · 2022: $651 · 2023: $59.21 · 2024: $301 · 2025: $49.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $409.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $742.59 | 2019-2024 | Xarelto |
| Inari Medical, INC. | $375.11 | 2021-2022 | |
| Nabriva Therapeutics, Plc | $208.87 | 2020 | |
| Kestra Medical Technology Services, INC. | $161.85 | 2024 | Assure Wcd |
| Vifor Pharma, INC. | $120.68 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $101.43 | 2019 | |
| Eagle Pharmaceuticals, INC. | $92.83 | 2024 | |
| Abbvie INC. | $88.50 | 2019 | |
| Heartflow, INC. | $49.84 | 2025 | |
| Abiomed | $30.93 | 2023 | Impella |
| Medtronic, INC. | $21.55 | 2021 | |
| Seqirus USA INC | $19.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yi Tang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.